346 related articles for article (PubMed ID: 8619026)
1. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC.
van Geel IP; Oppelaar H; Marijnissen JP; Stewart FA
Radiat Res; 1996 May; 145(5):602-9. PubMed ID: 8619026
[TBL] [Abstract][Full Text] [Related]
2. Optimisation of illumination for photodynamic therapy with mTHPC on normal colon and a transplantable tumour in rats.
Tsutsui H; MacRobert AJ; Curnow A; Rogowska A; Buonaccorsi G; Kato H; Bown SG
Lasers Med Sci; 2002; 17(2):101-9. PubMed ID: 12111593
[TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.
Schouwink H; Ruevekamp M; Oppelaar H; van Veen R; Baas P; Stewart FA
Photochem Photobiol; 2001 Apr; 73(4):410-7. PubMed ID: 11332037
[TBL] [Abstract][Full Text] [Related]
4. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy.
Sitnik TM; Henderson BW
Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590
[TBL] [Abstract][Full Text] [Related]
5. Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.
Murrer LH; Hebeda KM; Marijnissen JP; Star WM
Br J Cancer; 1999 May; 80(5-6):744-55. PubMed ID: 10360652
[TBL] [Abstract][Full Text] [Related]
6. Photosensitizing efficacy of MTHPC-PDT compared to photofrin-PDT in the RIF1 mouse tumour and normal skin.
van Geel IP; Oppelaar H; Oussoren YG; van der Valk MA; Stewart FA
Int J Cancer; 1995 Jan; 60(3):388-94. PubMed ID: 7829249
[TBL] [Abstract][Full Text] [Related]
7. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice.
Coutier S; Bezdetnaya LN; Foster TH; Parache RM; Guillemin F
Radiat Res; 2002 Sep; 158(3):339-45. PubMed ID: 12175311
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy for gastrointestinal tumors using three photosensitizers--ALA induced PPIX, Photofrin and MTHPC. A pilot study.
Mĺkvy P; Messmann H; Regula J; Conio M; Pauer M; Millson CE; MacRobert AJ; Bown SG
Neoplasma; 1998; 45(3):157-61. PubMed ID: 9717528
[TBL] [Abstract][Full Text] [Related]
9. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
10. Fluence rate-dependent intratumor heterogeneity in physiologic and cytotoxic responses to Photofrin photodynamic therapy.
Busch TM; Xing X; Yu G; Yodh A; Wileyto EP; Wang HW; Durduran T; Zhu TC; Wang KK
Photochem Photobiol Sci; 2009 Dec; 8(12):1683-93. PubMed ID: 20024165
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Dose Metrics to Predict Local Tumor Control for Photofrin-mediated Photodynamic Therapy.
Qiu H; Kim MM; Penjweini R; Finlay JC; Busch TM; Wang T; Guo W; Cengel KA; Simone CB; Glatstein E; Zhu TC
Photochem Photobiol; 2017 Jul; 93(4):1115-1122. PubMed ID: 28083883
[TBL] [Abstract][Full Text] [Related]
12. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen.
Busch TM; Wileyto EP; Emanuele MJ; Del Piero F; Marconato L; Glatstein E; Koch CJ
Cancer Res; 2002 Dec; 62(24):7273-9. PubMed ID: 12499269
[TBL] [Abstract][Full Text] [Related]
13. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal photodynamic therapy in the rat: comparison of toxicity profiles for photofrin and MTHPC.
Veenhuizen RB; Ruevekamp-Helmers MC; Helmerhorst TJ; Kenemans P; Mooi WJ; Marijnissen JP; Stewart FA
Int J Cancer; 1994 Dec; 59(6):830-6. PubMed ID: 7989125
[TBL] [Abstract][Full Text] [Related]
15. Foscan-based photodynamic treatment in vivo: correlation between efficacy and Foscan accumulation in tumor, plasma and leukocytes.
Maugain E; Sasnouski S; Zorin V; Merlin JL; Guillemin F; Bezdetnaya L
Oncol Rep; 2004 Sep; 12(3):639-45. PubMed ID: 15289849
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy with systemic meta-tetrahydroxyphenylchlorin in the treatment of anal intraepithelial neoplasia, grade 3.
van der Snoek EM; den Hollander JC; Aans JB; Sterenborg HJ; van der Ende ME; Robinson DJ
Lasers Surg Med; 2012 Oct; 44(8):637-44. PubMed ID: 22899359
[TBL] [Abstract][Full Text] [Related]
17. Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.
Krueger T; Pan Y; Tran N; Altermatt HJ; Opitz I; Ris HB
Lasers Surg Med; 2005 Oct; 37(4):271-7. PubMed ID: 16245295
[TBL] [Abstract][Full Text] [Related]
18. Interstitial 5-ALA photodynamic therapy and glioblastoma: Preclinical model development and preliminary results.
Tetard MC; Vermandel M; Leroy HA; Leroux B; Maurage CA; Lejeune JP; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2016 Mar; 13():218-224. PubMed ID: 26213327
[TBL] [Abstract][Full Text] [Related]
19. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
20.
Penjweini R; Kim MM; Ong YH; Zhu TC
Phys Med Biol; 2020 Jan; 65(3):03LT01. PubMed ID: 31751964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
